WRLD A.LIVE

00:001 report

• Dr Klobocista on Molecular Testing in Gynecologic Cancers Targeted Oncology

23:001 report

• Tumor Recurrence at the Tracheostomy Stoma Following Oncologic Surgery for Squamous Cell Carcinoma of the Tongue: A Case Report and Literature Review Cureus

22:002 reports

• IASCO Molecule Practicum – Season 3: Practical Foundations for Medical Oncology Oncodaily
• TGF-β-induced ganglioside remodeling highlights GD2 as a dynamically regulated target in glioblastoma Nature

21:00nothing heard

20:001 report

• "Vampire" Tumors: How Cancer Hijacks the Body's Resources Labroots

19:00nothing heard

18:00nothing heard

17:001 report

• Structural perturbations and destabilizing mutations in RAD51C and RAD51D reveal mechanisms of cancer risk Nature

16:00nothing heard

15:001 report

• Surgical De-escalation After Neoadjuvant Immunotherapy for Cutaneous Squamous Cell Carcinoma: Oncological Safety and Reconstructive Consequences Cureus

14:00nothing heard

13:00nothing heard

12:001 report

• Bacteriophage-based vaccine reduced tumor risk in mice — News-Medical UA.NEWS

11:001 report

• Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines News-Medical

10:002 reports

• Checkpoint immunotherapy reshapes immune environment in lymph nodes after melanoma reaches them Medical Xpress
• Traditional Chinese Medicine Formula Kills Drug-Resistant Cancer Cells in The Lab ScienceAlert

09:003 reports

• Glioblastoma organoids on the ISS replicated aggressive tumors more accurately — News-Medical UA.NEWS
• Space-grown glioblastoma organoids could help advance brain cancer treatments EurekAlert!
• New swab test could spare some women a painful biopsy for endometrial cancer Medical Xpress

08:001 report

• Living alone linked to higher risk of death from multiple causes BGNES

07:00nothing heard

06:002 reports

• Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer Diagnostic Imaging
• Structural perturbations and destabilizing mutations in RAD51C and RAD51D reveal mechanisms of cancer risk Nature

05:00nothing heard

04:002 reports

• Space-grown organoids better replicate aggressive glioblastoma tumors News-Medical
• Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes News-Medical

03:003 reports

• ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression Nature
• A 6.3M-Person Study Found This Link Between Early Adulthood & Cancer Yahoo Health
• Obesity in Your 20s and 30s Linked to Higher Cancer Risk Healthline

02:005 reports

• Space-grown glioblastoma organoids could help advance brain cancer treatments Medical Xpress
• Living Alone Linked to Mortality Risk From Multiple Causes in U.S. Including Cancer; Suicide Highest | Newswise Newswise
• This Lifestyle Factor Was Just Linked To A 27% Higher Mortality Risk MindBodyGreen
• Living Alone Riskier For Young And Middle-Aged Adults Than Seniors, Study Indicates U.S. News & World Report
• Lonely Cancer Deaths; 'Silence Was Deafening'; Mental Health and Cancer Mortality MedPage Today

01:007 reports

• Customizable nanoparticles improve cancer vaccine protection in mice Nanowerk
• Researchers identify ANO6 as a potential target against pancreatic cancer — News-Medical UA.NEWS
• Lowering cancer deaths in patients with mental illness | CO-CAPTAIN Project | Results in Brief | HORIZON CORDIS
• Technology Takes Aim at Psychological Distress in Patients with Cancer Cleveland Clinic
• Investigating how mental health and cancer survivorship intersect Stanford Medicine
• How mental health and cancer survivorship intersect Medical Xpress
• Targeting specific enzyme reverses radiation-induced immune suppression in cancer News-Medical

00:003 reports

• Targeting ANO6 protein weakens pancreatic cancer and boosts immunity News-Medical
• New Swab Test Could Spare Some Women A Painful Biopsy For Endometrial Cancer U.S. News & World Report
• Blocking Protein Slows Pancreatic Tumor Growth and Reduces Immune Suppression in Mice Genetic Engineering and Biotechnology News

23:008 reports

• Cancer-promoting proteins may make tumors easier to spot... but also help them evade immune attack Medical Xpress
• YAP/TAZ protein hyperactivity linked to immune evasion via PD-L2 upregulation Drug Target Review
• Cancer-promoting proteins may make tumors easier to spot but also help them evade immune attack Asia Research News |
• Omega-3 EPA tied to longer survival after liver surgery for bowel cancer spread Bioengineer.org
• Omega-3s Might Improve Survival In Advanced Cancer, Trial Finds U.S. News & World Report
• Subinguinal Orchidectomy for Testicular Tumour: A Regional Analysis of Oncological Control and Postoperative Outcomes Cureus
• Mesothelioma Study Links Asbestos Inflammation to Aggressive Tumor Growth Mesothelioma.net
• Customizable nanoparticles show potential for delivering personalized cancer vaccines Phys.org

22:00nothing heard

21:002 reports

• Orelabrutinib Combo Shows Durable Responses in Relapsed/Refractory CNS Lymphoma CancerNetwork
• A New Era in Pancreatic Cancer Treatment: Daraxonrasib Shakes Up the Landscape OncLive

20:001 report

• Why some “lower-risk” childhood cancers turn deadly Science Daily

19:006 reports

• Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment Medical Xpress
• Vitamin C improves survival rate after blood cancer What Doctors Don't Tell You
• Could Oral Vitamin C Confer OS Benefit in CCUS and Lower-Risk MDS? CancerNetwork
• What Nurses Should Tell Patients About Vitamin C in CCUS and MDS Oncology Nursing News
• Activating cancer-fighting protein could make T-cell immunotherapies more effective, study finds UCLA Health
• p53 activation boosts T-cell potency against solid tumours Drug Target Review

18:001 report

• Why some “lower-risk” childhood cancers turn deadly Science Daily

17:002 reports

• Perforin: Michigan researchers find immune protein kills cancer by overloading it with iron Open Access Government
• Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis News-Medical

16:001 report

• Surgeon Recommendations on Thyroidectomy Vary Widely in Low-Risk Thyroid Cancer Medscape

15:00nothing heard

14:002 reports

• KRAS Drug Resistance Has Upstream Cause: METTL13 Enzyme Fuels Tumor Protein Overload Tech Times
• Clinical, Prognostic, and Survival Implications of Vitamin B12 Levels in Cancer Patients Following Chemo- or Radiotherapy Cureus

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:001 report

• Belly fat in young adults linked to higher cancer risk, with women facing steeper odds: study 헤럴드경제

07:001 report

• A protein that regulates mRNA decoding can itself be regulated with implications for understanding cancer Phys.org

06:002 reports

• Newly found enzyme pathway helps cancer cells churn out KRAS growth proteins Bioengineer.org
• Newly Discovered Pathway Fuels Production of Cancer-Driving Proteins | Newswise Newswise

05:003 reports

• What Does ‘In Clinical Trial’ Actually Mean? – Ovarian Cancer Research Foundation Oncodaily
• Residential fine particulate matter linked to minimal residual disease in pediatric leukemia Medical Xpress
• Shifts Seen in Real-world DOAC Use for Cancer-Associated VTE TCTMD.com

04:001 report

• Immune system protein is a cancer killer on its own, new study shows Medical Xpress

03:007 reports

• Obesity in Young Adults Associated with Higher Risk for Early-Onset Cancer | Newswise Newswise
• Obesity In Young Adulthood Linked To Increased Risk Of Early-Onset Cancer U.S. News & World Report
• Adults in their 20s and 30s with severe obesity: 1 in 38 diagnosed with cancer within 10 years... ‘Belly fat’ riskier than BMI 스포츠조선
• Obesity in Young Adulthood Linked to Higher Cancer Risk Into Midlife Pharmacy Times
• Growth Hormone Peptide in Oncology: Clinical Evaluation of Safety EMJ
• METTL13 helps cancer cells produce proteins for tumor growth — News-Medical UA.NEWS
• New study identifies potential targets for KRAS-related treatment resistance News-Medical

02:009 reports

• FDA Approves Rasonque for Previously Treated Advanced Pancreatic Cancer Denkstrom
• Oral Pan-RAS Inhibitors: What’s Next for Pancreatic Cancer Treatment? GeneOnline
• Shubham Pant: What’s Next in Pancreatic Cancer? Oncodaily
• PanCAN Marks Pancreatic Cancer Awareness Month with New Hope as Breakthroughs in Treatments Signal a New Era for Patients Pancreatic Cancer Action Network
• Prior Regimen Did Not Affect Daraxonrasib Benefit in Pretreated Pancreatic Cancer CancerNetwork
• Study identifies translation regulation mechanisms involved in cancer development and treatment resistance | Newswise Newswise
• Methylated eEF1A selectively decodes mRNA to shape cancer proteomes Nature
• Newly discovered pathway fuels production of cancer-driving proteins UT MD Anderson
• New mechanism helps cancer cells selectively produce proteins that drive tumor growth News-Medical

01:00nothing heard

00:001 report

• A bioinformatic resource for pan-cancer proteomics research News-Medical

22:001 report

• Iron Deficiency Without Anaemia Still Carries Cancer Risk EMJ

21:002 reports

• In the US, B-SYNC CAR-T cells eliminated glioma in mice — News-Medical UA.NEWS
• Brain-Activated CAR T Therapy Advances Toward Clinical Testing for Pediatric Cancer Technology Networks

20:004 reports

• Roswell Park Study Identifies Early Window When Prostate Tumors May Respond Better to Immunotherapy The Ritz Herald
• Roswell Park Researchers Identify Critical Window for Boosting Immunotherapy Response in Prostate Cancer Roswell Park Comprehensive Cancer Center
• Researchers identify critical window for boosting immunotherapy response in prostate cancer Medical Xpress
• Applying Belantamab Mafodotin in Community Practice CancerNetwork

19:005 reports

• Veracyte (VCYT) Could Be 16% Undervalued On Decipher And Prosigna Progress Simply Wall Street
• Diagnostic test could flag which men need aggressive prostate cancer treatment and which don't Fox News
• Advancements in Classifying Prostate Cancer Can Inform Treatment Decisions Labroots
• Bispecific antibody targets regulatory T cells to enhance tumour immunity Drug Target Review
• Connecting discoveries to advance cancer research at TAU The Jerusalem Post

18:002 reports

• Synchronous Occurrence of Thyroglossal Duct Cyst-Derived Papillary Carcinoma and Papillary Thyroid Carcinoma: A Case Report and Literature Review Cureus
• A new tissue atlas will help AI understand cancer EPFL News

17:00nothing heard

16:001 report

• Less common HPV types linked to survival differences in Korean throat cancer study Korea Biomedical Review

15:001 report

• Wilbur Lam: Proud of Kendall Williams for Advancing Precision Medicine in Pediatric Leukemia Oncodaily

14:001 report

• Primary Synovial Sarcoma of the Thyroid: Radiological and Pathological Correlation of a Rare Malignancy Cureus

13:00nothing heard

12:002 reports

• Smarter CAR-T cells could beat a deadly pediatric brain cancer Medical Xpress
• Immune changes linked to diabetes could guide development of new cancer treatments Medical Xpress

11:003 reports

• Smarter CAR-T cells could beat a deadly pediatric brain cancer EurekAlert!
• UCSF scientists develop smart CAR-T cells to fight childhood brain tumors News-Medical
• Beyond BRAF V600: emerging MAPK-targeted therapeutic strategies Annals of Translational Medicine

10:002 reports

• Wider surgical margins may not mean better cancer control Medical Xpress
• Narrow surgical margins may safely remove childhood soft tissue sarcomas News-Medical

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:001 report

• Tumour assembloids recapitulate tumour–CAF–T cell crosstalk in renal cancer Nature

05:00nothing heard

04:003 reports

• New UChicago-built tools predict how cancer responds to treatment by studying ‘floor plans’ of tumors UChicago News
• New tissue atlas aims to help AI understand cancer Phys.org
• Customizable DNA labels can selectively guide drug carriers to cancer cells Phys.org

03:002 reports

• Lab-on-a-chip predicts which cancer treatments may work for pediatric acute lymphoblastic leukemia Medical Xpress
• Beyond the Initial Impression: Diagnostic Anchoring in an Elderly Patient With Metastatic Gallbladder Cancer Cureus

02:004 reports

• AI and molecular studies converge to decode cancer complexity in new research collection Bioengineer.org
• Can AI Find the Cure? American Enterprise Institute - AEI
• Machine Learning Models Outperform Traditional Approaches to Multicancer Risk Prediction The ASCO Post
• Extracellular vesicle discovery may shed light on how cancer spreads Phys.org

01:005 reports

• Study identifies common mechanism behind widespread cancer mutations News-Medical
• Personalized ovarian cancer vaccines spark immunity in phase 1 trial Medical Xpress
• A unifying mechanism for cancer-driving mutations Cornell Chronicle
• McGill University Health Centre researchers make discovery regarding migrating cancer cells CityNews Montreal
• Discovery of a potential new vehicle for cancer spread McGill University Health Centre

00:002 reports

• Arsenic drug combo resurrects 'guardian of the genome' to fight aggressive blood cancers Medical Xpress
• Unifying mechanism explains how common cancer mutations fuel growth Medical Xpress

22:003 reports

• Cell-level analysis reveals how ovarian tumors may develop resistance to chemotherapy Medical Xpress
• How zombie cancer cells evade chemotherapy’s effects Chemical & Engineering News
• Scalp Swelling Caused by Extracranial Extension of Meningioma Cureus

21:002 reports

• Preclinical research shows macrophages can be programmed to fight solid cancer tumors Medical Xpress
• Overcoming cancer stigma requires policy changes and public education News-Medical

20:003 reports

• Clinical Scenario 2, Discussion of Treatment Goals, AUGMENT-101, and Antifungal Selection in Relapsed KMT2A-Rearranged AML CancerNetwork
• She took birth control for acne. It started ‘feeding’ a hidden cancer USA Today
• Fighting cancer also means fighting against social stigma Medical Xpress

19:001 report

• Discovery Of Potential New Vehicle For Cancer Spread Mirage News

18:008 reports

• Fewer low-risk prostate cancers treated as active surveillance becomes the norm Bioengineer.org
• Active surveillance used as less invasive prostate cancer option WRGB
• How has the treatment of low-risk prostate cancer evolved in the US? Oncology Central
• Radiotherapy Highlights Local Risks in Bile Duct Cancer EMJ
• Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal The Manila Times
• Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA News-Medical
• EMT2 trial reports higher survival with high-dose EPA UA.NEWS
• Can Omega-3 Supplements Prolong Life in Metastatic CRC? Medscape

17:002 reports

• Do Home Radon Levels Affect Risk for Brain Cancer? Medscape
• Study Reveals How Tumors Invade and Grow in the Brain Technology Networks

16:001 report

• New Tissue Atlas Will Help AI Understand Cancer Mirage News

15:00nothing heard

14:00nothing heard

13:00nothing heard

12:00nothing heard

11:001 report

• US develops chip to assess response to childhood leukemia treatment — News-Medical UA.NEWS

10:001 report

• Lab-on-a-chip technology helps predict childhood leukemia treatment responses News-Medical

09:00nothing heard

08:00nothing heard

07:001 report

• Guideline on shorter-course radiation therapy for localized prostate cancer updated Medical Xpress

06:002 reports

• Virtual Tumor Models Reveal Promising Treatment Strategies for Triple-Negative Breast Cancer Inside Precision Medicine
• ESMO 2026: RADIAN Trial Reports Improved Disease-Free Survival With Niraparib, Dostarlimab and Chemoradiotherapy in Locally Advanced Head and Neck Cancer Oncodaily

05:001 report

• Glioblastoma's secret weapon: Silencing the brain's off switch Medical Xpress

04:001 report

• Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer News-Medical

03:003 reports

• AstraZeneca may start work on cancer vaccines, CEO says By Investing.com Investing.com South Africa
• AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says Quartz
• AstraZeneca May Enter Cancer Vaccine Development, CEO Says Bloomberg.com

02:002 reports

• GORTEC IDEAL Trial Reports Encouraging Early Safety Results With EGFR-Targeted ADC and Immunotherapy in Head and Neck Cancer Oncodaily
• Baylor researchers discover how glioblastoma hijacks nearby brain cells News-Medical

01:002 reports

• Blocking cellular communication reduces the spread of deadly glioblastoma News-Medical
• Cisplatin-Free Pembrolizumab Regimen Misses Primary End Point in SMART-KEY CancerNetwork

00:008 reports

• Scrotal Skin Cancer Incidence Rises in US Medscape
• Bispecific Immunotherapy Shows Early Activity in Treatment-Resistant Solid Tumors Inside Precision Medicine
• ESMO 2026: Marengo’s bispecific antibody shrinks 8 tumor types in Phase 2 BioSpace
• Humaid Al-Shamsi։ First-in-Human Results Presented for Novel T-Cell Therapy in Advanced Solid Tumors Oncodaily
• A precision T-cell therapy stalls treatment-resistant cancers in clinical trial National Institutes of Health (NIH) | (.gov)
• Experimental T-cell therapy shows promise against treatment-resistant cancers Open Access Government
• Liquid Biopsy Market to Reach USD 29.2 Billion by 2036, Driven openPR.com
• Liquid Biopsy Cancer Screening Faces a Steep Climb From Lab Promise to Clinical Proof Bioengineer.org

23:002 reports

• New leukemia drug suppresses cancer-driving protein more strongly than existing treatments within one week Medical Xpress
• ASTRO updates guideline on shorter-course radiation therapy for localized prostate cancer | Newswise Newswise

22:003 reports

• Natalia Baran at LeukO 2026: The Next Breakthrough in CML May Be Life Without Treatment Oncodaily
• Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia News-Medical
• Single-cell sequencing data shows how pancreatic cancer tumors evolve to resist therapy Drug Discovery News

21:00nothing heard

20:001 report

• Hidden bacterial compounds reveal potential cancer drug leads Drug Target Review

19:004 reports

• Scientists create 500 models to predict the risk of 20 types of cancer — News-Medical UA.NEWS
• Artificial intelligence allows detecting people at higher risk of cancer, according to a new international study. Demócrata
• Emad Shash: Why AI in Cancer Care Needs Both Vision and Clinical Judgment? Oncodaily
• Machine learning models predict common cancer risks using routine health data News-Medical

18:001 report

• Symbolic AI-driven "Digital Twins" predict personalised cancer treatments Open Access Government

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:001 report

• Cryopreservation techniques for adult and pediatric glioblastoma organoids and their effects on stem cell self-renewal Nature

13:003 reports

• Cerebrospinal fluid liquid biopsy detects tumor DNA in complex brain cases News-Medical
• The Surprising Clues BMI May Miss in Head and Neck Cancer Medscape
• Exploring the potential of immunotherapy in early-stage triple-negative breast cancer Medical Xpress

12:001 report

• One antibody, three targets: New strategy against triple-negative breast cancer American Society for Biochemistry and Molecular Biology

11:00nothing heard

10:00nothing heard

09:002 reports

• New AI platform helps uncover promising cancer drug combinations UCLA Health
• Scientists discover hidden weaknesses in microtubules stabilized by a cancer drug Asia Research News |

08:002 reports

• Sac-TMT Improves PFS and OS, Is Under FDA Priority Review in Previously Treated Endometrial Cancer OncLive
• MRK: Positive Phase 3 results for sac-TMT and intismeran underpin a broad oncology pipeline TradingView

07:001 report

• Personalized cancer vaccine plus immunotherapy reduces melanoma recurrence after surgery Medical Xpress

06:008 reports

• New players provide hope in imatinib-resistant GIST FirstWord Pharma
• We are going to cure cancer. AI will help us do it Washington Times
• AI Gives Pathologists "Super Vision": A New Era in Cancer Detection Vocal
• Anna Geguchadze: How AI Is Reshaping Young Oncologists’ Daily Work? Oncodaily
• Running Toward a Cure: Reflections at “Next Conversations” The Johns Hopkins News-Letter
• Jame Abraham: Anbenitamab Shows Promising PFS Benefit in HER2+ Advanced Breast Cancer Oncodaily
• Results From a Phase III Clinical Study of Anbenitamab in Combination With Docetaxel for Injection for the First-Line Treatment of HER2-Positive Advanced Breast Cancer FirstWord Pharma
• Moderna CEO Confident Cancer Vaccines Will Work Beyond Melanoma Bloomberg.com

05:005 reports

• Moderna’s Rally May Have Run Out of Steam. Here’s What to Watch Next Investopedia
• Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Phase 3 Trial XenoSpectrum
• Obesity in Young Adults Linked to Multiple Early Cancers MedPage Today
• Liver Metastases OS Not Tied to Surgical Method Used Medscape
• Silent bacterial genes yield potential leads for future cancer drugs Phys.org

04:002 reports

• Cryopreservation techniques for adult and pediatric glioblastoma organoids and their effects on stem cell self-renewal Nature
• Location of rare cancer impacts survival, study suggests Medical Xpress

03:004 reports

• Digital tumour models predicted treatment response in 74% of cases — News-Medical UA.NEWS
• Reduced-Frequency Immunotherapy Fails to Demonstrate Noninferiority in Advanced Cancer in Phase 3 MOIO Trial HMP Global Learning Network
• UCL scientists design symbolic AI digital twins to treat cancer News-Medical
• Sac-TMT Improves Survival vs Chemotherapy in Pretreated Endometrial Cancer CancerNetwork

02:0012 reports

• KEYNOTE-C93 Shows PFS Benefit With First-Line Pembrolizumab Monotherapy in dMMR Endometrial Cancer OncLive
• Six-Gene Score Could Improve Survival Predictions for Acute Myeloid Leukemia The Indian Practitioner
• Predicting Leukemia Survival May Be Aided by Six Gene Scoring System Genetic Engineering and Biotechnology News
• Smart probe makes aggressive breast cancer cells glow during surgery News-Medical
• MIT implant could stop deadly brain tumors from coming back ttownmedia.com
• Mount Sinai Medical Center Physician Leads Global Phase 3 Trial Showing Chemotherapy-Free Treatment Improves Outcomes for Women with dMMR Endometrial Cancer Morningstar
• Pembrolizumab Alone Exceeds Chemo in First-Line dMMR Endometrial Cancer Targeted Oncology
• Tumor Budding in Invasive Breast Carcinoma: Association With Histopathological Features and Hormone Receptor Status Cureus
• Merck drug extends survival in endometrial cancer trial, wins US priority review Reuters
• US shifts away from treating low-risk prostate cancer — News-Medical UA.NEWS
• Hossam Abdulkhalek: Dato-DXd in TNBC Brain Metastases - Practice-Changing or Practice-Generating? Oncodaily
• Datroway Shows Encouraging Results for Triple-Negative Breast Cancer That Has Spread to the Brain https://news.cancerconnect.com/

01:008 reports

• Merck's Sac-TMT Lowers Risk of Death 32% in Advanced Endometrial Cancer Trial marketscreener.com
• TroFuse-005 at ESMO 2026: Sacituzumab Tirumotecan Significantly Improves Overall Survival in Advanced Endometrial Cancer Oncodaily
• Implantable device uses ultrasound to improve drug delivery to the brain MIT News
• Brain Implant Could Prevent Glioblastoma Relapse with Ultrasound Drug Delivery Inside Precision Medicine
• Merck's therapy extends survival in hard-to-treat uterine cancer patients TradingView
• ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer BioSpace
• Merck Drug Boosts Survival From Hard-to-Treat Uterine Cancer Bloomberg.com
• AI could help identify people at higher risk of common cancers using routine health data Medical Xpress

00:006 reports

• ESMO 2026: Survival Gains and New Treatment Strategies in GI Cancers Targeted Oncology
• Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer NYU Langone Health
• Mount Sinai Medical Center Physician Leads Global Phase 3 Trial Showing Chemotherapy-Free Treatment Improves Outcomes for Women with dMMR Endometrial Cancer PR Newswire
• ESMO: In sac-TMT’s first global phase 3 win, Merck sees ‘pretty consistent’ data with China Fierce Pharma
• Beyond the cancer vaccine, how did Merck’s oncology pipeline do at ESMO? Endpoints News
• Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer – Company Announcement Financial Times

23:003 reports

• Interpath-001: data leak, stock drop, spirited defense by ESMO president BioWorld News
• Individualizing Treatment in Multiple Myeloma CancerNetwork
• PFS, MRD, and Treatment Duration in Multiple Myeloma CancerNetwork

22:001 report

• Next-generation drug reduces endometrial cancer progression and death in trial Medical Xpress

21:004 reports

• Aydah AlAwadhi: Advancing Personalized mRNA Cancer Vaccines in High-Risk Melanoma Oncodaily
• Moderna seeks FDA approval for intismeran as soon as possible — STAT News UA.NEWS
• Psychological Distress Common in Patients With Cancer, Nurse Scientist Says Oncology Nursing News
• Population-Level Shifts in Cervical Cancer Stage Distribution in the United States Following Human Papillomavirus (HPV) Vaccine Implementation Cureus

20:004 reports

• In vivo engineered CAR NK cells Nature
• Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function – Company Announcement Financial Times
• How Cancer Cells React to Loss of Amino Acid Depends on Their Cell State Technology Networks
• IL-21 mimic synergizes with KRAS inhibitors Nature

19:006 reports

• Moderna Stock Forecast: MRNA Holds $181.36 Support After Positive Cancer Vaccine Data Sparks a Selloff TradingKey
• World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial ScienceAlert
• [Column] Could cancer vaccines open a new era in cancer treatment? Korea Biomedical Review
• Torvu-Sam Elicits Responses & Manageable Safety Across FRα Expression Levels in PROC OncLive
• Cancer Findings Support Calls for Improved LP Care Medscape
• GBH Daily: An invitation WGBH

18:006 reports

• Personalized Melanoma Vaccine Improves RFS in Phase 3 Trial Medscape
• 'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer Genetic Literacy Project
• Moderna CEO on what’s next after success in cancer vaccine STAT
• mRNA vaccine reduced risk of melanoma recurrence or death by 42% — ScienceAlert UA.NEWS
• Menna Fouda: What Should Oncologists Know About mRNA Cancer Vaccines? Oncodaily
• Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer NPR

17:003 reports

• A Single Case of Durable Nivolumab Response in Oropharyngeal Cancer Medscape
• Rare Nipple Melanoma Case Exposes Diagnostic Challenges EMJ
• SMART-KEY at ESMO 2026: Pembrolizumab-Based Strategy Achieves 65.1% Laryngectomy-Free Survival in Advanced Laryngeal Cancer Oncodaily

16:002 reports

• Interventional radiology underrepresented in cancer guideline development Radiology Business
• Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment Medical Xpress

15:00nothing heard

14:002 reports

• Beyond mutations: new study reveals alternative route to cancer Science Tokyo
• Research Finds Alternative Pathway to Cancer Beyond Mutations Mirage News

13:002 reports

• INTerpath-001 Data Detail Survival, Subgroup, and Safety Findings in Melanoma CancerNetwork
• #ESMO26: Merck and Moderna’s cancer vaccine data were ‘a triumph of science.’ And now, the work begins Endpoints News

12:005 reports

• The ESMO presentation everyone’s been waiting for STAT
• Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Drug Makers Report The New York Times
• Sinor Soltanizadeh: Could Personalized Cancer Vaccines Shape the Future of Gynaecological Oncology? Oncodaily
• MRNA: Intismeran plus pembrolizumab improved RFS and DMFS in phase III melanoma TradingView
• World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial Yahoo

11:00nothing heard

10:00nothing heard

09:001 report

• Diffuse Large B-Cell Lymphoma Presenting as an Isolated Inguinal Mass in a 19-Year-Old Male Patient Cureus

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:00nothing heard

04:003 reports

• 5 doctors weigh in on the promise, limitations of Grail’s multicancer test MedTech Dive
• J&J Reports 77% Response Rate For Rybrevant Faspro In First-Line Head And Neck Cancer TradingView
• New treatment combination shows promising results in recurrent head and neck cancer The Institute of Cancer Research

03:00nothing heard

02:002 reports

• New triple therapy could shrink cancer tumours LBC
• NRG-GY020 Trial Finds No Added Benefit of Pembrolizumab With Adjuvant Radiotherapy in Early-Stage Endometrial Cancer Oncodaily

01:001 report

• AGITG MASTERPLAN Trial Shows Improved Local Control and Survival With SBRT Plus Chemotherapy in Pancreatic Cancer Oncodaily

00:002 reports

• Cancer cells enter "zombie-like state" to evade chemotherapy, reveals new research Yahoo
• An Integrated Approach to Cervical Cancer Prevention Based on WHO’s 90-70-90 Targets: A Rural Community-Based Study Cureus